Regulation of apoptosis and cell survival by resveratrol

Mini-Reviews in Organic Chemistry

Volumn 7, Issue 4, 2010, Pages 262-266

  Fulda, Simone ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Apoptosis; Cancer; Resveratrol

Indexed keywords

CANCER CELLS; CELL SIGNALING; CHEMOTHERAPY; DISEASES; PHYSIOLOGY; RESVERATROL; SIGNAL TRANSDUCTION; TISSUE;

ANTITUMOUR ACTIVITY; CANCER; CANCER CELLS; CANCER THERAPY; CELL SURVIVAL; CONDITION; HUMAN DISEASE; NATURAL COMPOUNDS; PROGRAMMED CELL DEATHS; SIGNALING EVENTS;

CELL DEATH;

EID: 77958168860     PISSN: 1570193X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157019310792246355     Document Type: Article

References (67)

1. Lockshin, R.A., Zakeri, Z. Cell death in health and disease. J. Cell Mol. Med., 2007, 11(6), 1214-1224.
2. Fulda, S., Debatin, K.M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene, 2006, 25(34), 4798-4811.
3. Fulda, S., Debatin, K.M. Apoptosis signaling pathways in anticancer therapy. Curr. Cancer Ther. Rev., 2008, 4, 14-20.
4. Fulda, S. Tumor resistance to apoptosis. Int. J. Cancer, 2009, 124(3), 511-515.
5. Lowe, S.W., Cepero, E., Evan, G. Intrinsic tumour suppression. Nature, 2004, 432(7015), 307-315.
6. Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I.L., Korkina, O., Teng, X., Abbott, D., Cuny, G.D., Yuan, C., Wagner, G., Hedrick, S.M., Gerber, S.A., Lugovskoy, A., Yuan, J. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol., 2008, 4(5), 313-321.
7. Taylor, R.C., Cullen, S.P., Martin, S.J. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol., 2008, 9(3), 231-241.
8. Degterev, A., Boyce, M., Yuan, J. A decade of caspases. Oncogene, 2003, 22(53), 8543-8567.
9. Ashkenazi, A. Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev., 2008, 19(3-4), 325-331.
10. Adams, J.M., Cory, S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene, 2007, 26(9), 1324-1337.
11. Kroemer, G., Galluzzi, L., Brenner, C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev., 2007, 87(1), 99-163.
12. LaCasse, E.C., Mahoney, D.J., Cheung, H.H., Plenchette, S., Baird, S., Korneluk, R.G. IAP-targeted therapies for cancer. Oncogene, 2008, 27(48), 6252-6275.
13. Okada, H., Mak, T.W. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat. Rev. Cancer, 2004, 4(8), 592-603.
14. Maiuri, M.C., Zalckvar, E., Kimchi, A., Kroemer, G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol., 2007, 8(9), 741-752.
15. Kirkegaard, T., Jaattela, M. Lysosomal involvement in cell death and cancer. Biochim. Biophys. Acta, 2009, 1793(4), 746-754.
16. Festjens, N., Vanden Berghe, T., Vandenabeele, P. Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. Biochim. Biophys. Acta, 2006, 1757(9-10), 1371-1387.
17. Kondo, Y., Kanzawa, T., Sawaya, R., Kondo, S. The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer, 2005, 5(9), 726-734.
18. Pervaiz, S. Resveratrol: from grapevines to mammalian biology. FASEB J., 2003, 17(14), 1975-1985.
19. Gusman, J., Malonne, H., Atassi, G. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis, 2001, 22(8), 1111-1117.
20. Pervaiz, S., Holme, A.L. Resveratrol: its biologic targets and functional activity. Antioxid. Redox. Signal., 2009, 11(11), 2851-2897.
21. Stivala, L.A., Savio, M., Carafoli, F., Perucca, P., Bianchi, L., Maga, G., Forti, L., Pagnoni, U.M., Albini, A., Prosperi, E., Vannini, V. Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J. Biol. Chem., 2001, 276(25), 22586-22594.
22. Zykova, T.A., Zhu, F., Zhai, X., Ma, W.Y., Ermakova, S.P., Lee, K.W., Bode, A.M., Dong, Z. Resveratrol directly targets COX-2 to inhibit carcinogenesis. Mol. Carcinog., 2008, 47(10), 797-805.
23. Cal, C., Garban, H., Jazirehi, A., Yeh, C., Mizutani, Y., Bonavida, B. Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities. Curr. Med. Chem. Anti-Cancer Agents, 2003, 3(2), 77-93.
24. Fulda, S., Debatin, K.M. Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res., 2004, 64(1), 337-346.
25. Roy, P., Kalra, N., Prasad, S., George, J., Shukla, Y. Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways. Pharm. Res., 2009, 26(1), 211-217.
26. Aziz, M.H., Afaq, F., Ahmad, N. Prevention of ultraviolet-B radiation damage by resveratrol in mouse skin is mediated via modulation in survivin. Photochem. Photobiol., 2005, 81(1), 25-31.
27. Yu, L.J., Wu, M.L., Li, H., Chen, X.Y., Wang, Q., Sun, Y., Kong, Q.Y., Liu, J. Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells. Neoplasia, 2008, 10(7), 736-744.
28. Singh, S.K., Moretta, D., Almaguel, F., Wall, N.R., De Leon, M., De Leon, D. Differential effect of proIGF-II and IGF-II on resveratrol induced cell death by regulating survivin cellular localization and mitochondrial depolarization in breast cancer cells. Growth Factors, 2007, 25(6), 363-372.
29. Hayashibara, T., Yamada, Y., Nakayama, S., Harasawa, H., Tsuruda, K., Sugahara, K., Miyanishi, T., Kamihira, S., Tomonaga, M., Maita, T. Resveratrol induces downregulation in survivin expression and apoptosis in HTLV-1-infected cell lines: a prospective agent for adult T cell leukemia chemotherapy. Nutr. Cancer, 2002, 44(2), 193-201.
30. Bhardwaj, A., Sethi, G., Vadhan-Raj, S., Bueso-Ramos, C., Takada, Y., Gaur, U., Nair, A.S., Shishodia, S., Aggarwal, B.B. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood, 2007, 109(6), 2293-2302.
31. Jazirehi, A.R., Bonavida, B. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol. Cancer Ther., 2004, 3(1), 71-84.
32. Kotha, A., Sekharam, M., Cilenti, L., Siddiquee, K., Khaled, A., Zervos, A.S., Carter, B., Turkson, J., Jove, R. Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Mol. Cancer Ther., 2006, 5(3), 621-629.
33. Gledhill, J.R., Montgomery, M.G., Leslie, A.G., Walker, J.E. Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols. Proc. Natl. Acad. Sci. USA, 2007, 104(34), 13632-13637.
34. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., Geny, B., Laakso, M., Puigserver, P., Auwerx, J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell, 2006, 127(6), 1109-1122.
35. Biasutto, L., Mattarei, A., Marotta, E., Bradaschia, A., Sassi, N., Garbisa, S., Zoratti, M., Paradisi, C. Development of mitochondria-targeted derivatives of resveratrol. Bioorg. Med. Chem. Lett., 2008, 18(20), 5594-5597.
36. Jeong, S.H., Jo, W.S., Song, S., Suh, H., Seol, S.Y., Leem, S.H., Kwon, T.K., Yoo, Y.H. A novel resveratrol derivative, HS1793, overcomes the resistance conferred by Bcl-2 in human leukemic U937 cells. Biochem. Pharmacol., 2009, 77(8), 1337-1347.
37. Morrison, D.K. The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol., 2009, 19(1), 16-23.
38. Clement, M.V., Hirpara, J.L., Chawdhury, S.H., Pervaiz, S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood, 1998, 92(3), 996-1002.
39. Karin, M., Cao, Y., Greten, F.R., Li, Z.W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer, 2002, 2(4), 301-310.
40. Hayden, M.S., Ghosh, S. Shared principles in NF-kappaB signaling. Cell, 2008, 132(3), 344-362.
41. Holmes-McNary, M., Baldwin, A.S., Jr. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res., 2000, 60(13), 3477-3483.
42. Manna, S.K., Mukhopadhyay, A., Aggarwal, B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol., 2000, 164(12), 6509-6519.
43. Yeung, F., Hoberg, J.E., Ramsey, C.S., Keller, M.D., Jones, D.R., Frye, R.A., Mayo, M.W. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J., 2004, 23(12), 2369-2380.
44. Howitz, K.T., Bitterman, K.J., Cohen, H.Y., Lamming, D.W., Lavu, S., Wood, J.G., Zipkin, R.E., Chung, P., Kisielewski, A., Zhang, L.L., Scherer, B., Sinclair, D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 2003, 425(6954), 191-196.
45. Blander, G., Guarente, L. The Sir2 family of protein deacetylases. Annu. Rev. Biochem., 2004, 73, 417-435.
46. Estrov, Z., Shishodia, S., Faderl, S., Harris, D., Van, Q., Kantarjian, H.M., Talpaz, M., Aggarwal, B.B. Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood, 2003, 102(3), 987-995.
47. Rambaldi, A., Torcia, M., Bettoni, S., Vannier, E., Barbui, T., Shaw, A.R., Dinarello, C.A., Cozzolino, F. Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells. Blood, 1991, 78(12), 3248-3253.
48. Roy, P., Kalra, N., Nigam, N., George, J., Ray, R.S., Hans, R.K., Prasad, S., Shukla, Y. Resveratrol enhances ultraviolet B-induced cell death through nuclear factor-kappaB pathway in human epidermoid carcinoma A431 cells. Biochem. Biophys. Res. Commun., 2009, 384(2), 215-220.
49. Benitez, D.A., Hermoso, M.A., Pozo-Guisado, E., Fernandez-Salguero, P.M., Castellon, E.A. Regulation of cell survival by resveratrol involves inhibition of NF kappa B-regulated gene expression in prostate cancer cells. Prostate, 2009, 69(10), 1045-1054.
50. Banerjee, S., Bueso-Ramos, C., Aggarwal, B.B. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res., 2002, 62(17), 4945-4954.
51. Kang, S.S., Cuendet, M., Endringer, D.C., Croy, V.L., Pezzuto, J.M., Lipton, M.A. Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB. Bioorg. Med. Chem., 2009, 17(3), 1044-1054.
52. Shaw, R.J., Cantley, L.C. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature, 2006, 441(7092), 424-430.
53. She, Q.-B., Huang, C., Zhang, Y., Dong, Z. Involvement of c-jun NH(2)-terminal kinases in resveratrol-induced activation of p53 and apoptosis. Mol. Carcinog., 2002, 33(4), 244-250.
54. Kaneuchi, M., Sasaki, M., Tanaka, Y., Yamamoto, R., Sakuragi, N., Dahiya, R. Resveratrol suppresses growth of Ishikawa cells through down-regulation of EGF. Int. J. Oncol., 2003, 23(4), 1167-1172.
55. Lee, M.H., Choi, B.Y., Kundu, J.K., Shin, Y.K., Na, H.K., Surh, Y.J. Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target. Cancer Res., 2009, 69(18), 7449-7458.
56. Pozo-Guisado, E., Lorenzo-Benayas, M.J., Fernandez-Salguero, P.M. Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int. J. Cancer, 2004, 109(2), 167-173.
57. Jiang, H., Shang, X., Wu, H., Gautam, S.C., Al-Holou, S., Li, C., Kuo, J., Zhang, L., Chopp, M. Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells. J. Exp. Ther. Oncol., 2009, 8(1), 25-33.
58. Zamin, L.L., Filippi-Chiela, E.C., Dillenburg-Pilla, P., Horn, F., Salbego, C., Lenz, G. Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells. Cancer Sci., 2009, 100(9), 1655-1662.
59. Yu, R., Hebbar, V., Kim, D.W., Mandlekar, S., Pezzuto, J.M., Kong, A.N. Resveratrol inhibits phorbol ester and UV-induced activator protein 1 activation by interfering with mitogen-activated protein kinase pathways. Mol. Pharmacol., 2001, 60(1), 217-224.
60. Huang, C., Ma, W.Y., Goranson, A., Dong, Z. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis, 1999, 20(2), 237-242.
61. She, Q.B., Bode, A.M., Ma, W.Y., Chen, N.Y., Dong, Z. Resveratrol- induced activation of p53 and apoptosis is mediated by extracellular- signal-regulated protein kinases and p38 kinase. Cancer Res., 2001, 61(4), 1604-1610.
62. Miloso, M., Bertelli, A.A., Nicolini, G., Tredici, G. Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells. Neurosci. Lett., 1999, 264(1-3), 141-144.
63. Madan, E., Prasad, S., Roy, P., George, J., Shukla, Y. Regulation of apoptosis by resveratrol through JAK/STAT and mitochondria mediated pathway in human epidermoid carcinoma A431 cells. Biochem. Biophys. Res. Commun., 2008, 377(4), 1232-1237.
64. Li, H., Wu, W.K., Zheng, Z., Che, C.T., Yu, L., Li, Z.J., Wu, Y.C., Cheng, K.W., Yu, J., Cho, C.H., Wang, M. 2,3',4,4',5'-Pentamethoxy-trans-stilbene, a resveratrol derivative, is a potent inducer of apoptosis in colon cancer cells via targeting microtubules. Biochem. Pharmacol., 2009, 78(9), 1224-1232.
65. Yang, Y.T., Weng, C.J., Ho, C.T., Yen, G.C. Resveratrol analog- 3,5,4'-trimethoxy-trans-stilbene inhibits invasion of human lung adenocarcinoma cells by suppressing the MAPK pathway and decreasing matrix metalloproteinase-2 expression. Mol. Nutr. Food Res., 2009, 53(3), 407-416.
66. Boocock, D.J., Faust, G.E., Patel, K.R., Schinas, A.M., Brown, V.A., Ducharme, M.P., Booth, T.D., Crowell, J.A., Perloff, M., Gescher, A.J., Steward, W.P., Brenner, D.E. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol. Biomarkers Prev., 2007, 16(6), 1246-1252.
67. Ahmad, K.A., Clement, M.V., Hanif, I.M., Pervaiz, S. Resveratrol inhibits drug-induced apoptosis in human leukemia cells by creating an intracellular milieu nonpermissive for death execution. Cancer Res., 2004, 64(4), 1452-1459.